EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Computational analysis of Ayurvedic metabolites for potential treatment of drug-resistant Candida auris

Mohibullah Shah, Mahnoor Zia, Iqra Ahmad, Muhammad Umer Khan, Hasan Ejaz, Maqsood Alam, Shahid Aziz, Umar Nishan, Hanna Dib, Riaz Ullah, Suvash Chandra Ojha

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1537872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Mohibullah Shah und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan. Hauptthemen laut MEDLINE: Antifungal Agents, Medicine, Ayurvedic, Candida auris, Drug Resistance, Fungal. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explored the effectiveness of secondary metabolites of referred traditional Ayurvedic plants in treating fungal infections, particularly targeting Candida auris . Recognized as a global health threat, this fungus is notorious for its resistance to several antifungal treatments. The inhibition of lanosterol 14α-demethylase causes the depletion of ergosterol, ultimately resulting in the inhibition of fungal cell growth. A total of 469 metabolites, including alkaloids, flavonoids, and tannins from Ayurvedic plants, were screened against CYP51 (PDB ID: 4UYL) using molecular docking. Key active site residues, namely HIS461, CYS463, and TYR122, were targeted to inhibit the ergosterol synthesis, with VNI employed to benchmark the findings. Shortlisted metabolites underwent physicochemical analysis, ADMET analyses, and the principles of medicinal chemistry, which were confirmed through pharmacokinetic simulations. Further, this study investigated the molecular dynamics (MD) of co-crystalized VNI, trans-p-coumaric acid, and MCPHB [(r)-n-(1’-methoxycarbonyl-2’-phenylethyl)-4-hydroxybenzamide] to evaluate RMSD, RMSF, Rg, SASA, cross-correlation of residue motions, PCA, and free energy decomposition. The top compounds demonstrated favorable drug-like criteria. They exhibited good absorption potential with high gastrointestinal uptake. Distribution and metabolism were manageable with low risks of drug-drug interactions. Excretion profiles indicated proper clearance, and toxicity assessments showed low potential for cardiovascular issues. The results showed stable interactions for trans-p-coumaric acid and MCPHB, suggesting that all the ligands maintain stable binding interactions with the protein, which preserves structural integrity across all systems. This comprehensive approach suggests that these natural metabolites from Ayurvedic medicine could potentially serve as primary agents against fungal diseases, pending further validation through controlled in vitro and in vivo clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsMedicine, AyurvedicCandida aurisDrug Resistance, FungalPlant ExtractsMolecular Docking SimulationMolecular Dynamics SimulationHumansCytochrome P450 Family 51ErgosterolMicrobial Sensitivity TestsCatalytic DomainFlavonoids

Stichwörter der Autor:innen

Candida auriscomputational chemistryfungal infectionsmolecular dockingplants

Substanzen

Antifungal AgentsPlant ExtractsCytochrome P450 Family 51ErgosterolFlavonoids

Autor:innen und Institutionen

  • Department of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan.
  • Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia.
  • Department of Biochemistry and Molecular Biology, Federal University of Ceara, Fortaleza, Brazil.
  • Department of Chemistry, Kohat University of Science and Technology, Kohat, Pakistan.
  • College of Engineering and Technology, American University of the Middle East, Egaila 54200, Kuwait.

Zitieren

APA

Shah, M., Zia, M., Ahmad, I., Umer Khan, M., Ejaz, H., Alam, M., Aziz, S., Nishan, U., Dib, H., Ullah, R., & Ojha, S. C. (2025). Computational analysis of Ayurvedic metabolites for potential treatment of drug-resistant Candida auris. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1537872

Vancouver

Shah M, Zia M, Ahmad I, Umer Khan M, Ejaz H, Alam M, et al. Computational analysis of Ayurvedic metabolites for potential treatment of drug-resistant Candida auris. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1537872

BibTeX
@article{Shah2025,
  author = {Shah, Mohibullah and Zia, Mahnoor and Ahmad, Iqra and Umer Khan, Muhammad and Ejaz, Hasan and Alam, Maqsood and Aziz, Shahid and Nishan, Umar and Dib, Hanna and Ullah, Riaz and Ojha, Suvash Chandra},
  title = {Computational analysis of Ayurvedic metabolites for potential treatment of drug-resistant Candida auris},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1537872}
}
Kostenlos starten →